Correction to: Interrogation of novel CDK2/9 inhibitor fadraciclib (CYC065) as a potential therapeutic approach for AML.
Wittawat ChantkranYa-Ching HsiehDaniella ZhelevaSheelagh FrameHelen WheadonMhairi CoplandPublished in: Cell death discovery (2021)